June 3, 2024
Zydus Americas had a 94% employee survey response rate and 90% of employees described the company as a great place to work. Solana Beach, CA, and Ahmedabad, India – June 3, 2024 — Sentynl Therapeutics, Inc. (Sentynl), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. (Zydus Group) today announced that it received accreditation […]